Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drug Discovery in Liver Disease Using Kinome Profiling. | Int J Mol Sci | 2021 | 33807722 | PubTator, text mining | PubMed |
| Mesenchymal-Epithelial Transition in Fibroblasts of Human Normal Lungs and Interstitial Lung Diseases. | Biomolecules | 2021 | 33806618 | PubTator, text mining | PubMed |
| The Role of the Receptor Tyrosine Kinase Axl in Carcinogenesis and Development of Therapeutic Resistance: An Overview of Molecular Mechanisms and Future Applications. | Cancers (Basel) | 2021 | 33806258 | PubTator, text mining | PubMed |
| RNA-seq Characterization of Melanoma Phenotype Switch in 3D Collagen after p38 MAPK Inhibitor Treatment. | Biomolecules | 2021 | 33802847 | PubTator, text mining | PubMed |
| Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer. | Int J Mol Sci | 2021 | 33802033 | PubTator, text mining | PubMed |
| Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations. | Oncotarget | 2021 | 33796225 | PubTator, text mining | PubMed |
| Association of tumor mutation burden and epidermal growth factor receptor inhibitor history with survival in patients with metastatic stage III/IV non-small-cell lung cancer: A retrospective study. | Clinics (Sao Paulo) | 2021 | 33787673 | PubTator, text mining | PubMed |
| The expression of two collagen receptor subfamilies, integrins and discoidin domains during osteogenic and chondrogenic differentiation of human mesenehymal stem cells. | Biomed Mater Eng | 2021 | 33780357 | PubTator, text mining | PubMed |
| Dysregulation of lncRNAs in Rheumatoid Arthritis: Biomarkers, Pathogenesis and Potential Therapeutic Targets. | Front Pharmacol | 2021 | 33776780 | PubTator, text mining | PubMed |
| The Binary Classification of Protein Kinases. | J Inflamm Res | 2021 | 33776467 | PubTator, text mining | PubMed |
| Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches. | Semin Liver Dis | 2021 | 33764481 | PubTator, text mining | PubMed |
| The Clinical and Pathological Characteristics of Malignant Struma Ovarii: An Analysis of 144 Published Patients. | Front Oncol | 2021 | 33763376 | PubTator, text mining | PubMed |
| Identification of Differential Expression Cytokines in Hemolysis, Elevated Liver Enzymes, and Low Platelet Syndrome by Proteome Microarray Analysis and Further Verification. | Cell Transplant | 2021 | 33757334 | PubTator, text mining | PubMed |
| Mutational spectrum and precision oncology for biliary tract carcinoma. | Theranostics | 2021 | 33754015 | PubTator, text mining | PubMed |
| Mutational landscape and potential therapeutic targets for sporadic pancreatic neuroendocrine tumors based on target next-generation sequencing. | Exp Ther Med | 2021 | 33747156 | PubTator, text mining | PubMed |
| Swiss-PO: a new tool to analyze the impact of mutations on protein three-dimensional structures for precision oncology. | NPJ Precis Oncol | 2021 | 33737716 | PubTator, text mining | PubMed |
| Bioactive potential of natural biomaterials: identification, retention and assessment of biological properties. | Signal Transduct Target Ther | 2021 | 33737507 | PubTator, text mining | PubMed |
| A ligand-receptor interactome platform for discovery of pain mechanisms and therapeutic targets. | Sci Signal | 2021 | 33727337 | PubTator, text mining | PubMed |
| Underlying mechanisms and drug intervention strategies for the tumour microenvironment. | J Exp Clin Cancer Res | 2021 | 33722297 | PubTator, text mining | PubMed |
| DNAJC12 as a Mediator Between ESR1 and ERBB4 in Breast Carcinoma Cells. | Front Oncol | 2021 | 33718139 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=50